This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Scios Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Linda Slanec Higgins: Innovator in Neurodegenerative Research
Introduction
Linda Slanec Higgins is a notable inventor based in Palo Alto, California. She has made significant contributions to the field of neurodegenerative research, particularly in the identification of compounds that can reduce beta-amyloid levels, which are associated with Alzheimer's disease.
Latest Patents
Linda holds a patent for "Methods to identify β-amyloid reducing agents." This invention provides methods that can be used to identify β-amyloid reducing compounds. The present invention is based on the use of organotypic brain slice culturing methods to simultaneously assess the toxicity and β-amyloid reducing activity of a test compound. She has 1 patent to her name.
Career Highlights
Linda is currently employed at Scios Inc., where she continues her research and development efforts. Her work focuses on innovative approaches to combat neurodegenerative diseases, contributing to advancements in medical science.
Collaborations
One of her notable coworkers is Barbara Cordell, who collaborates with Linda on various research projects. Their combined expertise enhances the potential for groundbreaking discoveries in their field.
Conclusion
Linda Slanec Higgins exemplifies the spirit of innovation in the realm of neurodegenerative research. Her contributions are paving the way for new treatments and understanding of complex neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile